Håvard Hauge • 1969 • Oslo • 8 roles • 8 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
B BIOMOLEX AS	Managing Director/CEO	22,800	-	11.3 % indirectly
P PUBGENE AS	Managing Director/CEO	2,894,213	18,960,345	-

Boards

Name	Role	Total operating income	Total equity	Shares
C CEROLU AS	Chairman	306,150	-199,896	100 % directly
B BIOMOLEX AS	Board Member	22,800	-	11.3 % indirectly
C COREMINE VITAE AS	Board Member	2,069,446	1,691,173	6.68 % directly 6.59 % indirectly 0.09 %
V VITAE EVIDENCE AS	Chairman	533,106	-	6.5 % directly 5.46 % indirectly 1.04 %
C COREMINE BIL	Board Member	-	-	-
P PUBGENE AS	Board Member	2,894,213	18,960,345	-

Last update: Aug 17, 2023

Related industries2

Direct relationships5

EN
Eirik Næss-Ulseth1956
COREMINE BIL, PUBGENE AS, BIOMOLEX AS, VITAE EVIDENCE AS, COREMINE VITAE AS
JR
Jorun Ruud1969
COREMINE VITAE AS
WH
Werner Hosewinckel Christie1949
COREMINE VITAE AS
TK
Tina Kihlstrand Hauge1973
CEROLU AS
IM
Ivar Magne Årnes1961
COREMINE VITAE AS

Shares owned by Håvard Hildeng Hauge

Name	Share class	Total operating income	Total equity	Share
C CEROLU AS	Ordinære aksjer	306,150	-199,896	100 % directly
B BIOMOLEX AS		22,800	0	11.3 % indirectly
C COREMINE VITAE AS	Ordinære aksjer	2,069,446	1,691,173	6.59 % directly 6.59 % indirectly 0.09 %
V VITAE EVIDENCE AS	Ordinære aksjer	533,106	0	5.46 % directly 5.46 % indirectly 1.04 %
A ARCTIC PHARMA AS		1,018,191	2,005,323	3 % indirectly
R RHEUMATECH AS	Ordinære aksjer	7,000	0	1.16 % directly
A AIRTHINGS AS	NO0010895568	427,455,000	333,775,000	0.72 % directly < 0.01 %
S SPERMATECH AS	NO0010291057	443,352	304,768	< 0.01 % directly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025